» Articles » PMID: 20035217

Risk Factors and Outcome of Transfusion-related Acute Lung Injury in the Critically Ill: a Nested Case-control Study

Overview
Journal Crit Care Med
Date 2009 Dec 26
PMID 20035217
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To determine the incidence, risk factors, and outcome of transfusion-related acute lung injury in a cohort of critically ill patients.

Design: In a retrospective cohort study, patients with transfusion-related acute lung injury were identified using the consensus criteria of acute lung injury within 6 hrs after transfusion. Inclusion criterion was a length of intensive care unit admission >48 hrs. Patients developing transfusion-related acute lung injury were matched (on age, sex, and admission diagnosis) to transfused control subjects and patients developing acute lung injury from another origin.

Setting: Tertiary referral hospital.

Patients: All first-admitted patients from November 1, 2004, until October 1, 2007, to the intensive care unit.

Interventions: None.

Measurements And Main Results: Of 5208 admitted patients, 2024 patients had a length of stay >48 hrs, of whom 109 were suspected transfusion-related acute lung injury cases. Compared with transfused control subjects, risk factors for transfusion-related acute lung injury were emergency cardiac surgery (odds ratio, 17.6 [1.8-168.5]), hematologic malignancy (odds ratio, 13.1 [2.7-63.8]), massive transfusion (odds ratio, 4.5 [2.1-9.8]), sepsis (odds ratio, 2.5 [1.2-5.2]), mechanical ventilation (odds ratio, 3.0 [1.3-7.1], and high Acute Physiology and Chronic Health Evaluation II score (odds ratio, 1.1 [1.0-1.1]; p < .03 for all). The volume of platelets and plasma transfused was associated with transfusion-related acute lung injury in the univariate analysis. However, this association disappeared in the multivariate analysis. Compared with acute lung injury control subjects, risk factors for transfusion-related acute lung injury were sepsis (odds ratio, 2.4 [1.1-5.3]) and high Acute Physiology and Chronic Health Evaluation II score (odds ratio, 1.1 [1.0-1.1]), whereas pneumonia (odds ratio, 0.4 [0.2-0.7]) was a negative predictive factor. Patients with transfusion-related acute lung injury had a longer duration of mechanical ventilation compared with transfused control subjects and acute lung injury control subjects (231 [138-472] vs. 71 [46-163] and 70 [42-121] hrs, p < .001). Also, 90-day survival of patients with transfusion-related acute lung injury was lower compared with transfused control subjects and acute lung injury control subjects (53% vs. 75% and 83%, p < .02).

Conclusions: Transfusion-related acute lung injury is common in critically ill patients. Transfusion-related acute lung injury may contribute to an adverse outcome associated with transfusion. This study identifies transfusion-related acute lung injury risk factors, which may aid in assessing the risks and benefits of transfusion in critically ill patients.

Citing Articles

Incidence, outcome and risk factors of perioperative pulmonary complications in pediatric patients with mediastinal mass.

Feng J, Zhao J, Zhang Y, Hu Y BMC Pediatr. 2025; 25(1):108.

PMID: 39939872 PMC: 11817565. DOI: 10.1186/s12887-025-05419-9.


Plasma transfusion in the intensive care unit.

van Haeren M, Raasveld S, de Bruin S, Reuland M, van den Oord C, Schenk J Transfusion. 2024; 65(1):73-87.

PMID: 39696779 PMC: 11747124. DOI: 10.1111/trf.18071.


Transfusion-related acute lung injury (TRALI) following intravenous immunoglobulin infusion in a rituximab immunosuppressed patient with long-shedding SARS-CoV-2.

Degtiarova G, Conen A, Klarer A, Arifi T, Guldimann G, Finkener S BMC Infect Dis. 2024; 24(1):916.

PMID: 39232646 PMC: 11373488. DOI: 10.1186/s12879-024-09809-9.


Transfusion-Related acute lung injury (TRALI) caused by antibodies to HLA-DRB1* 07:01 and HLA-DQB1*02:02: A case report.

Huang M, Wang X, Wang L, Chen G Clin Case Rep. 2023; 11(12):e8284.

PMID: 38107079 PMC: 10724081. DOI: 10.1002/ccr3.8284.


Update on transfusion-related acute lung injury: an overview of its pathogenesis and management.

Yu Y, Lian Z Front Immunol. 2023; 14:1175387.

PMID: 37251400 PMC: 10213666. DOI: 10.3389/fimmu.2023.1175387.